Lilly says its experimental GLP-1 pill better than Novo's Rybelsus in diabetes study

Eli Lilly on Wednesday said its experimental pill led to more weight loss and better control of blood sugar in patients with diabetes than oral semaglutide, the active ingredient in Danish rival Novo ... ...